Alembic Pharmaceuticals Limited

Price Chart

Risk-Adjusted Performance

Alembic Pharmaceuticals Limited (APLLTD) Price Performance

Alembic Pharmaceuticals Limited (APLLTD) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR784.75, up 4.87% from the previous close.

Over the past year, APLLTD has traded between a low of INR655.95 and a high of INR1027.67. The stock has lost 7.3% over this period. It is currently 23.6% below its 52-week high.

Alembic Pharmaceuticals Limited has a market capitalization of $147.09B, with a price-to-earnings ratio of 22.93.

About Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.